Search clinical trials for: Diroximel Fumarate

Total 1568 results

Biogen

Completed

A Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Diroximel Fumarate (DRF) in Chinese and Caucasian Adult Healthy Participants

Healthy Volunteers

New Zealand, Hong Kong
Biogen

Terminated

Exploring Diroximel Fumarate Real-world Experience in Canada and Israel (EXPER-CA/IL)

Relapsing Forms of MS

Israel
University of Nebraska

Not yet recruiting

Impact of Nrf2 Activation on Macrovascular, Microvascular & Leg Function & Walking Capacity in Peripheral Artery Disease

Peripheral Arterial Disease | Peripheral Vascular Diseases | Peripheral Arterial Occlusive Disease | Peripheral Artery Disease

United States
Banner Life Sciences LLC

Completed

Bioequivalence Study of Bafiertam 190 mg and Vumerity® 462 mg Delayed-Release Capsules in Fasting Healthy Subjects

Relapsing Remitting Multiple Sclerosis

United States
Biogen

Terminated

Study of Diroximel Fumarate in the Real-World Setting

Relapsing Forms of MS

United States
Biogen

Recruiting

A Study of Diroximel Fumarate (DRF) in Adult Participants From the Asia-Pacific Region With Relapsing Forms of Multiple Sclerosis (RMS)

Relapsing Forms of Multiple Sclerosis

China, Japan
Biogen

Not yet recruiting

A Study to Evaluate Long-Term Safety of Vumerity and Tecfidera in Participants With Multiple Sclerosis (MS)

Multiple Sclerosis
Biogen

Recruiting

Pregnancy Exposure Registry for Vumerity (Diroximel Fumarate)

Multiple Sclerosis

United States, Germany
Monash University

Enrolling by invitation

Relationship Between Oral DMT Burden and Adherence in MS (STATURE)

Multiple Sclerosis | Adherence, Medication

Australia
Swiss Federal Institute of Technology
University of Zurich; University Children's Hospital, Zurich; Jomo Kenyatta University...

Completed

The Effect of Human Milk Oligosaccharides and Galacto-oligosaccharides on Iron Absorption in Kenyan Infants (FeHMOGOS)

Anemia, Iron-deficiency

Kenya
AstraZeneca
Parexel

Completed

Formoterol Dose Ranging Study (ACHIEVE Duaklir USA Phase IIb)

Chronic Obstructive Pulmonary Disease - COPD

United States
Xi'an Xintong Pharmaceutical Research Co.,Ltd.

Unknown

A Study to Investigate the Safety, Tolerability, Pharmacokinetics of Single and Multiple Doses of Hepenofovir Fumarate Tablets in Healthy Volunteers.

Chronic Hepatitis b
Albion
Sprim Advanced Life Sciences

Unknown

A Study to Compare the Gastrointestinal Tolerability of Ferrochel®, Sumalate®,Ferrous Fumarate, Ferrous Sulfate, Ferric Glycinate, and Placebo

Anemia

Indonesia
Swiss Federal Institute of Technology

Completed

The Effect of Different Prebiotics on Iron Absorption From High Dose Iron Supplements

Iron-deficiency

Switzerland
Novartis Pharmaceuticals

Recruiting

Open Label Randomized Multicenter to Assess Efficacy & Tolerability of Ofatumumab 20mg vs. First Line DMT in RMS (STHENOS)

Multiple Sclerosis

Germany, Spain, Italy, France, United Kingdom
University Health Network, Toronto

Active, not recruiting

Study of CFI-400945 Fumarate in Patients With Relapsed or Refractory AML or MDS

Acute Myeloid Leukemia | Myelodysplastic Syndromes | Relapsed Cancer | Refractory Cancer

Canada
Banner Life Sciences LLC

Completed

Study to Compare GI Tolerability Following Oral Administration of Bafiertam™ or Tecfidera to Healthy Volunteers

Multiple Sclerosis

United States
South Australian Health and Medical Research Institute
Flinders University

Completed

Do Iron Supplements Impact the Gut Microbiome of Women of Reproductive Age?

Iron-deficiency | Anemia | Microbial Colonization

Australia
Swiss Federal Institute of Technology
Burgerstein Vitamine

Completed

Effect of Prebiotics on Iron Absorption in Women With Low Iron Stores (Fe_GOS_1)

Iron-deficiency

Switzerland
Prince of Songkla University
The Thai Society of Hematology

Completed

Thrice-weekly Versus Thrice-daily Oral Ferrous Fumarate Treatment in Adult Patients With Iron Deficiency Anemia

Iron Deficiency Anemia

Thailand
Nucorion Pharmaceuticals, Inc.
Medpace, Inc.; Ligand Pharmaceuticals

Completed

Safety, Tolerability and Pharmacokinetics of NCO-48 Fumarate in Healthy Subjects

Hepatitis B

United States
Isabelle Herter-Aeberli
Burgerstein Vitamine

Completed

Determination of Iron Absorption Mechanism From Ferrous Fumarate With GOS (Fe_GOS_3)

Low Iron Stores

Switzerland
Banner Life Sciences LLC

Enrolling by invitation

Observational Study of Persistence on Bafiertam Treatment In Routine Clinical Practice (SIMPLE)

Relapsing Remitting Multiple Sclerosis

United States, Puerto Rico
Galapagos NV

Completed

Oral Bioavailability of Two Solid Formulations of GLPG0259.

Healthy

Belgium
Thomas Walczyk

Unknown

Effect of Iron Status on Occurrence of Non-transferrin-bound Iron (NTBI) in Serum in Response to an Oral Iron Load

Effect of Iron Status on Occurrence of NTBI

Singapore
Biogen

Completed

A Healthy Volunteer Study to Establish the Bioequivalence of BG00012 Supplied by 2 Different Commercial Manufacturers

Healthy

United States
National Institute on Drug Abuse (NIDA)
University of Minnesota

Completed

Role of Metabolites in Nicotine Dependence (4) - 13

Tobacco Use Disorder

United States
Xuanwu Hospital, Beijing

Terminated

Impact of an Immune Modulator Dimethyl Fumarate on Acute Ischemic Stroke

Acute Ischemic Stroke

China
Biogen

Completed

Real World Analysis on Lymphocyte Reconstitution After Lymphopenia in Participants Treated by Tecfidera (Lympho-TEC)

Multiple Sclerosis | Multiple Sclerosis, Relapsing-Remitting

France
Sunnybrook Health Sciences Centre

Completed

Oral Iron vs. Placebo in Newly Diagnosed Gynecologic Oncology Patients Who Are Surgical Candidates.

Cervical Cancer | Anemia | Ovarian Cancer | Uterine Cancer

Canada
Almirall, S.A.

Completed

Efficacy and Safety of Tildrakizumab in Participants With Moderate-to-Severe Chronic Plaque Psoriasis Who Are Non-Responders to Dimethyl Fumarate Therapy (TRANSITION)

Plaque Psoriasis

United Kingdom, Germany
Banner Life Sciences LLC

Completed

Comparative Bioavailability of BAFIERTAM™ (Monomethyl Fumarate) and Tecfidera® (Dimethyl Fumarate) in Healthy Subjects

Relapsing Remitting Multiple Sclerosis
Isabelle Herter-Aeberli
Burgerstein Vitamine

Completed

Determination of a Dose-dependent Effect of GOS on Iron Absorption, and Addition of Vitamin C (Fe_GOS_2)

Iron-deficiency

Switzerland
Liverpool University Hospitals NHS Foundation Trust

Recruiting

EffiCacy and sAfEty of Low doSe orAl iRon for Anaemia in IBD (CAESAR)

Iron Deficiency Anemia | Inflammatory Bowel Disease

United Kingdom
Sixth Affiliated Hospital, Sun Yat-sen University

Completed

Optimization of Vonoprazan--amoxicillin Dual Therapy for Eradicating Helicobacter Pyloriinfection

Helicobacter Pylori Eradication Rate

China
Beijing Tiantan Hospital
Beijing Chao Yang Hospital; Henan Provincial People's Hospital; Beijing Neurosurgical...

Not yet recruiting

Dimethyl Fumarate Treatment for Intracranial Unruptured Aneurysms.

Intracranial Aneurysm | Aneurysm, Brain | Inflammation Vascular

China
University at Buffalo

Completed

Tecfidera Diffusion Tensor Imaging (DTI)

Multiple Sclerosis, Dimethyl Fumarate, Diffusion Tensor Imaging Magnetic Resonance Imaging
National Institute on Drug Abuse (NIDA)
University of Minnesota

Completed

Role of Metabolites in Nicotine Dependence (1) - 1

Tobacco Use Disorder

United States
National Institute on Drug Abuse (NIDA)
University of Minnesota

Completed

Role of Metabolites in Nicotine Dependence (2) - 5

Tobacco Use Disorder

United States
Fondation Ophtalmologique Adolphe de Rothschild

Terminated

Monitoring of Patients Followed for a Multiple Sclerosis and Treated by Dimethyl-fumarate (SURV-SEP)

Multiple Sclerosis, Relapsing-Remitting

France
National Institutes of Health (NIH)

Completed

Cereals as a Source of Iron for Breastfed Infants (Bfe03B)

Iron Deficiency

United States
Genesis Pharma CNS & Specialty

Completed

Study to Assess Resource Utilization and Quality of Life of Patients With RRMS Treated With Tecfidera in Greece (FIDELITY)

RRMS

Greece
Biogen

Completed

Study of the Effect of BG00012 on MRI Lesions and Pharmacokinetics in Pediatric Subjects With RRMS (FOCUS)

Multiple Sclerosis, Relapsing-Remitting

Poland, Turkey, United States, Latvia, Lebanon, Germany, Belgium, Bulgaria, Czechia, Kuwait
Universitätsmedizin Mannheim
Klinikum Ludwigshafen; Wuerzburg University Hospital; KKS Netzwerk; Klinikum Minden and other collaborators

Completed

Study on Therapy With Dimethylfumarate (DMF) in Patients With Cutaneous T Cell Lymphoma (CTCL) (DMF-CTCL)

Cutaneous T Cell Lymphoma

Germany
Virginia Simnad
Biogen

Unknown

Impact of Tecfidera on Gut Microbiota

Multiple Sclerosis

United States
University of Texas Southwestern Medical Center
Biogen

Completed

Assessment of Tecfidera® in Radiologically Isolated Syndrome (RIS) (ARISE)

Multiple Sclerosis (MS)

United States
Biogen

Completed

A Study Evaluating the Effectiveness of Tecfidera (Dimethyl Fumarate) on Multiple Sclerosis (MS) Disease Activity and Patient-Reported Outcomes (PROTEC)

Multiple Sclerosis | Relapsing-Remitting Multiple Sclerosis

France, Italy, Spain, Czechia, Hungary, Austria, Belgium, Canada, Portugal, Slovakia, Slovenia
Biogen

Completed

Extension Study of BG00012 in Pediatric Subjects With Relapsing Remitting Multiple Sclerosis (RRMS)

Multiple Sclerosis, Relapsing-Remitting

Poland, Belgium, Turkey, Bulgaria, United States, Czechia, Germany, Kuwait, Latvia, Lebanon
University Hospital Muenster
Biogen

Completed

Investigation of the Effect of Dimethyl Fumarate on T Cells in Patients With Relapsing Remitting Multiple Sclerosis (DIMAT-MS)

Multiple Sclerosis, Relapsing-Remitting

Germany
Biogen

Completed

Study Assessing Cognition in Relapsing Remitting Multiple Sclerosis (RRMS) Patients Treated With BG00012 (StarTec)

Multiple Sclerosis, Relapsing-Remitting

Italy

Search clinical trials for: Diroximel Fumarate

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Estonia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations